Special populations: The management of seizures in HIV-positive patients

Current Neurology and Neuroscience Reports

Volumn 4, Issue 4, 2004, Pages 308-314

  Mullin, Paul ^a   Green, Gary ^b   Bakshi, Rohit ^b  

^a NEUROLOGICAL INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; CARBAMAZEPINE; CORTICOSTEROID; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ETIRACETAM; GABAPENTIN; ISONIAZID; LAMIVUDINE; LAMOTRIGINE; NEVIRAPINE; OXCARBAZEPINE; PHENYTOIN; PLACEBO; PREGABALIN; PROTEINASE INHIBITOR; PYRIDOXINE; STAVUDINE; TENOFOVIR; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; ZALCITABINE; ZIDOVUDINE;

BEHAVIOR DISORDER; BODY WEIGHT DISORDER; CEREBROSPINAL FLUID EXAMINATION; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG PENETRATION; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; HOSTILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL DISEASE; MENTAL INSTABILITY; MOOD DISORDER; NERVOUSNESS; NEUROIMAGING; NEUROLOGIC DISEASE; PANCYTOPENIA; PATIENT CARE; PSYCHOSIS; REVIEW; SEIZURE; VIRUS REPLICATION; WEIGHT REDUCTION;

EID: 3543117713     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-004-0057-x     Document Type: Review

References (41)

1. Sempre AP, Villaverde FJ, Martinez-Menendez B, et al.: First seizure in adults: a prospective study from the emergency department. Acta Neurol Scand 1992, 86:134-138.
2. Bartolomei F, Pellegrino P, Dhiver C, et al.: Epilpetic Seizures in HIV infection. 52 cases. Presse Med 1991, 20:2135-2138.
3. Chada DS, Handa A, Sharma SK, et al.: Seizures in patients with human immunodeficiency virus infection. J Assoc Phys India 2000, 48:573-576.
4. Primavera A, Solaro C, Cocito L: De novo status epilepticus as the presenting sign of neurosyphllis. Epilesia 1998, 39:1367-1369.
5. Lechner C, Auer D, Kumfel T, et al.: Prolonged non-convulsive status epilepticus as an early clinical manifestation of epilepsy in connection with HIV infection - case report with EEG and MRI follow up. Fortschritte Der Neurologie-Psychiatrie 1998, 66:326-330.
6. Bartolomei F, Gavaret M, Dhiver C, et al.: Isolated, chronic, epilepsia partialis coontinua in an HIV-infected patient. Arch Neurol 1999, 56:111-114.
7. Moulignier A, Mikol J, Pialoux G, et al.: AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures. Am J Med 1995, 99:64-68.
8. Marsan A, Zivin LS: Factors related to the occurrence of typical paroxysmal abnormalities in the EEG records of epileptic patients. Epilepsia 1970, 11:361-381.
9. Bakshi R: Neuroimaging of HIV and Aids related illnesses: a review. Frontiers Biosci 2004, 9:632-646.
10. Thurner M, Thurner S, Fleischmann D, et al.: Comparison of T2-weighted and fluid-attenuated inversion-recovery fast spin-echo MR sequences in intracerebral AIDs-associated disease. Am J Neuroradiol 1997, 18:1601-1609.
11. Chinn R, Wilkinson I, Hall-Craggs M, et al.: Toxoplasmosis and primary central central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 1995, 197:649-654.
12. Villringer K, Jager H, Dichgans M, et al.: Differential diagnosis of CNS lesions in AIDS by FDG-PET. J Comput Assist Tomogr 1995, 19:532-536.
13. Update: serologic testing for HIV-1 antibody - United States, 1988 and 1989. Morb Mortal Wekly Rep 1990, 39:380-383.
14. Sloand EM, Pitt E, Chiarello RJ, Nemo GJ: HIV testing. State of the art. JAMA 1991, 266:2861.
15. Chraetien F, Baelec L, Hilton DA, et al.: Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 1996, 22:394.
16. Hamilton RL, Achim C, Grafe MR, et al.: Herpes simplex virus brainstem encephalitits in an AIDS patient. Clin Neuropathol 1995, 14:45.
17. Modi G, Martinus I, Vangu M: New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis - a clinical, radiological and SPECT scan study. J Neurol Sci 2002, 202:29-34.
18. Pesola GR, Westfal RE: New-onset seizures in patients with AIDS presenting to an emergency department. J Neurol Sci 1998, 161:180-184.
19. Morgello S, Black G, Price R, et al.: Varicella-zoster virus leukoencephalitis and cerebral vasculopathy. Arch Pathol Lab Med 1998, 112:173.
20. Pierson T, McArthur J, Silicano RF: Reservoirs of HIV-1 infection: mechanism for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000, 18:665-708.
21. Stingele K, Haas J, Zimmermann T, et al.: Independent HIV replication in paired CSF and blood viral isolate during antiretroviral therapy. Neurology 2001, 5655-5361.
22. Hugen PW, Burger DM, Brinkman K, et al.: Carbamazepine-indinivar interaction causes antiretroviral therapy failure. Ann Pharmacother 2000, 34:465-470.
23. Kato Y, Fuji T, Mizoguchi N, et al.: Potential interaction between ritonavir and carbamezipine. Pharmacotherapy 2000, 20:851-854.
24. Leppik IE, Gapany S, Walczak T: An HIV positive patient with epilepsy. Epilepsy Behav 2003, 4:S17-S19.
25. Witvrouw M, Schnidt JC, Van Remoortel B: Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retroviruses 1997, 13:187-192.
26. Simon G, Moor C, Obert G: Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus. Chem Biol Interact 1994, 91:111-121.
27. Cozza KL, Swanton EJ, Humphreys CW: Hepatotoxicity with a combination of valproic acid, ritonavir, and nevirapine: a case report. Psychomatics 2000, 41:452-453.
28. Pardo CA, McArthur JC, Griffin JW: HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Periph Nerv Syst 2001, 6:21-31.
29. Vitiello B, Burnam MA, Bing E, et al.: Use of psychotropic mediations among HIV-infected patient in the United States. Am J Psychiatry 2003, 160:547-554.
30. La Spina I, Porazzi D, Maggiolo F, et al.: Gabapentin in painful HIV-related neuropathy: a report of 19 patients preliminary observations. Eur J Neurol 2001, 8:71-75.
31. Brodie MJ, Chadwick DW, Anhut H, et al.: Gabapentin versus lamotrigine monotherapy: a double-blinded comparison in newly diagnosed epilepsy. Epilepsia 43:993-1000.
32. Shank RP, Gardocki JF, Streeter AJ, et al.: An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetecs, and mechanism of action. Epilepsia 2000, 41(suppl 1):S3-S9.
33. Garnet WR: Clinical pharmacology of topiramate: a review. Epilepsia 2000, 41(suppl 1):S61-S65.
34. Doose RD, Jacobs D, Squires L, et al.: Oral contraceptive-AED interactions: no effect of topiramate as monotherapy at clinically effective dosages of 200 mg or less. Paper presented at the American Epilepsy Society. Seattle, WA, December, 2002.
35. Janowsky DS: New treatments of bipolar disorder. Curr Psychiatry Rep 1999, 1:111-113.
36. Kline KM, Carroll DG, Malnar KF: Painful diabetic peripheral neuropathy relieved with the use of oral topiramate. South Med J 2003, 96:602-605.
37. Simpson D, Olney R, Mcarthur J, et al.: A placebo-controlled trial of lamotrigine for painful HIV associated neuropathy. Neurology 2000, 54:2115-2119.
38. Fiorenzo A, Roberto R, Agostino B: Oxcarbazapine interactions with other drugs. In Antiepileptic Drugs, edn 5. Edited by Levy RH, Mattson RH, Meldrum BS, Bashir KH. Philadelphia: Lippincott Williams & Wilkins; 2002:464-475.
39. Kramer G: Oxcarbazepine adverse effects. in Antiepileptic Drugs, edn 5. Edited by Levy RH, Mattson RH, Meldrum BS, Bashir KH. Philadelphia: Lippincott Williams & Wilkins; 2002:482-483.
40. Biton V: Levetiracetam adverse experiences. In Antiepileptic Drugs, edn 5. Edited by Levy RH, Mattson RH, Meldrum BS, Bashir KH. Philadelphia: Lippincott Williams & Wilkins; 2002:441-447.
41. Drug information Handbook 2002-2003, edn 10. Hudson, OH: Lexicomp; 2002:747-749.